RedHill Biopharma Ltd.

RDHL

US7574682024

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:30:00 07/06/2024 BST			5-day change	1st Jan Change
0.4319 ^USD	-6.43%		-5.72%	-70.42%

06-06	RedHill Biopharma Ltd. Announces Resignation of Alla Felders as Member of the Board	CI
05-06	Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib	MT

Redhill Biopharma Ltd. Announces Nicolas A. Weinstein, Director Not to Stand for Re-Election

April 20, 2020 at 12:01 pm

RedHill Biopharma Ltd. announced that Nicolas A. Weinstein a director notified the company that due to personal reasons he wishes not to stand for re-election at the upcoming shareholder meeting.

Latest news about RedHill Biopharma Ltd.

RedHill Biopharma Ltd. Announces Resignation of Alla Felders as Member of the Board	06-06	CI
Redhill Biopharma Awarded China Patent for Investigational Ebola Drug Opaganib	05-06	MT
RedHill Biopharma Ltd. Announces New Opaganib Chinese Patent against Ebola Virus Valid Through 2035	05-06	CI
RedHill Biopharma Ltd Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study	04-24	CI
RedHill Biopharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-08	CI
RedHill Biopharma Ltd. cancelled the transaction announced on March 8, 2023	03-27	CI
Redhill Biopharma Says Talicia Gets New US Patent to Treat Helicobacter Pylori Infection	03-11	MT
U.S. government Selects RedHill Biopharma Ltd.'s Opaganib for Evaluation by BARDA and NIH Countermeasures Programs	03-05	CI
Redhill Biopharma Ltd. Announces New Publication of Data from Multiple Experiments in the International Journal of Molecular Sciences	02-20	CI
Redhill Biopharma Closes $8 Million Registered Direct Offering of American Depositary Shares	01-26	MT
RedHill Biopharma to Seek Acquisitions	01-26	CI
ADRs Close Higher; Addex Therapeutics Climbs 21%	01-25	DJ
Top Midday Decliners	01-25	MT
Redhill Biopharma Launches $8 Million Offering of American Depositary Shares; Stock Falls	01-25	MT
ADRs Close Higher, Evaxion Biotech A/S Climbs 113.4%	01-24	DJ
Sector Update: Health Care Stocks Retreat Late Afternoon	12-20	MT
Sector Update: Health Care Stocks Mixed in Wednesday Afternoon Trading	12-20	MT
Redhill Says Opaganib, RHB-107 Combinations With Remdesivir Show 'Robust Synergistic Effect' Against Ebola; Shares Rise	12-20	MT
RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola	12-20	CI
ADRs End Lower, Redhill Biopharma Ltd. Declines 22.6%	12-06	DJ
U.S.-LISTED SHARES OF REDHILL BIOPHARMA RISE 2.4% ON ADDITIONAL…	12-04	RE
Redhill Biopharma Says it Received $4.8 Million in Additional Funds for Study of Early COVID-19 Treatment	12-04	MT
ADRs Close Higher; Akso Health Group Climbs 24%	12-01	DJ
ADRs Close Higher; Incannex Healthcare Inc. Climbs 723.7%	11-30	DJ
Top Premarket Decliners	11-30	MT

RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelersâ diarrhea. RedHillâs clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.

Sector

Pharmaceuticals

Calendar

14/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
REDHILL BIOPHARMA LTD.	-70.42%	13.76M
CSL LIMITED	+0.82%	91.94B
SAMSUNG BIOLOGICS CO.,LTD.	-1.32%	38.74B
BIOGEN INC.	-12.88%	32.82B
UCB	+64.77%	26.66B
BIOMARIN PHARMACEUTICAL INC.	-16.31%	15.32B
INCYTE CORPORATION	-5.78%	13.3B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-11.38%	11.65B
ALTEOGEN INC.	+173.10%	10.37B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-49.84%	10.12B

Biopharmaceuticals